Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69,013 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune response and homeostasis mechanism following administration of BBIBP-CorV SARS-CoV-2 inactivated vaccine.
Yin J, Zhao Y, Huang F, Yang Y, Huang Y, Zhuang Z, Wang Y, Wang Z, Lin X, Zheng Y, Zhou W, Wang S, Xu Z, Ye B, Guo Y, Lei W, Li L, Tian J, Gan J, Wang H, Wang W, Ma P, Liu C, Wei X, Shi X, Wang Z, Wang Y, Liu Y, Yang M, Yuan Y, Song Y, Ma W, Huang Z, Liu Y, Huang Y, Lu H, Liu P, Liang H, Hou Y, Xu X, Liu L, Zhang Y, Wu G, Gao GF, Jin X, Liu C, Yang X, Liu WJ. Yin J, et al. Among authors: yang m, yang x, yang y. Innovation (Camb). 2023 Jan 30;4(1):100359. doi: 10.1016/j.xinn.2022.100359. Epub 2022 Dec 5. Innovation (Camb). 2023. PMID: 36506806 Free PMC article.
Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models.
Zhang Y, Guo Y, Dong Y, Liu Y, Zhao Y, Yu S, Li S, Wu C, Yang B, Li W, Wei X, Zhang Y, Huang Y, Wang H, Yang X. Zhang Y, et al. Among authors: yang b, yang x. Hum Vaccin Immunother. 2022 Dec 30;18(7):2160158. doi: 10.1080/21645515.2022.2160158. Epub 2022 Dec 28. Hum Vaccin Immunother. 2022. PMID: 36576263 Free PMC article.
Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine.
Lu C, Zhang Y, Liu X, Hou F, Cai R, Yu Z, Liu F, Yang G, Ding J, Xu J, Hua X, Cheng X, Pan X, Liu L, Lin K, Wang Z, Li X, Lu J, Zhang Q, Li Y, Hu C, Fan H, Liu X, Wang H, Jia R, Xu F, Wang X, Huang H, Zhao R, Li J, Cheng H, Jia W, Yang X. Lu C, et al. Among authors: yang g, yang x. Antiviral Res. 2023 Apr;212:105556. doi: 10.1016/j.antiviral.2023.105556. Epub 2023 Mar 5. Antiviral Res. 2023. PMID: 36871919 Free PMC article.
Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in China.
Tang X, Xiao Y, Deng X, Zhou Y, Chen H, Yan R, Zhu Y, Wang S, Wang H, Zhu X, Luo L, Liu Y, Yin Z, Zhang G, Chen Z, Jiang J, Yang X, He H. Tang X, et al. Among authors: yang x. Lancet Reg Health West Pac. 2023 Mar 17;34:100725. doi: 10.1016/j.lanwpc.2023.100725. eCollection 2023 May. Lancet Reg Health West Pac. 2023. PMID: 37283972 Free PMC article.
Immunogenicity and safety of concomitant administration of the sabin-strain-based inactivated poliovirus vaccine, the diphtheria-tetanus-acellular pertussis vaccine, and measles-mumps-rubella vaccine to healthy infants aged 18 months in China.
Xu Y, Chen H, Wang B, Zhu X, Luo L, Wang S, Xiao Y, Wang H, Ma R, Liu S, Yan L, Li X, Chen D, Su Y, Chai Y, Fu J, Mao X, Cao J, Sun P, Tang F, Sun X, Wang Z, Yang X. Xu Y, et al. Among authors: yang x. Int J Infect Dis. 2023 Dec;137:9-15. doi: 10.1016/j.ijid.2023.10.006. Epub 2023 Oct 11. Int J Infect Dis. 2023. PMID: 37832931 Free article. Clinical Trial.
Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China.
Chen Y, Xiao Y, Ye Y, Jiang F, He H, Luo L, Chen H, Shi L, Mu Q, Chen W, Guo X, Zhang M, Li J, Guan Q, Chen Z, Yang X. Chen Y, et al. Among authors: yang x. Front Immunol. 2022 Dec 8;13:1080408. doi: 10.3389/fimmu.2022.1080408. eCollection 2022. Front Immunol. 2022. PMID: 36569946 Free PMC article. Clinical Trial.
69,013 results
You have reached the last available page of results. Please see the User Guide for more information.